Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Soluble adhesion molecules in Behçet's disease

D H Verity1, G R Wallace, P T Seed

  • 1Department of Ocular Immunology, Rayne Institute, St Thomas' Hospital, London, UK. dverity@rayne.umds.ac.uk

Ocular Immunology and Inflammation
|August 5, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Outcome of Staged Socket Surgery for Acquired Anophthalmos.

Ophthalmic plastic and reconstructive surgery·2023
Same author

Predicting spontaneous preterm birth in asymptomatic high-risk women with cervical cerclage.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2023
Same author

Orbital Exenteration for Advanced Periocular Adnexal Malignancies: Curative Versus Palliative Surgical Intent.

Ophthalmic plastic and reconstructive surgery·2022
Same author

Clinicians' experiences of using and implementing a medical mobile phone app (QUiPP V2) designed to predict the risk of preterm birth and aid clinical decision making.

BMC medical informatics and decision making·2021
Same author

Adamantiades-Behçet's disease (Behçet's disease) and COVID-19.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Ten women's decision-making experiences in threatened preterm labour: Qualitative findings from the EQUIPTT trial.

Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives·2021

Soluble ICAM-1 and VCAM-1 levels were lower in Behçet

Area of Science:

  • Ophthalmology
  • Immunology
  • Rheumatology

Background:

  • Behçet's disease (BD) can cause significant vision loss.
  • Elevated soluble ICAM-1 (sICAM-1) is linked to idiopathic uveoretinitis relapse and BD.
  • This study investigates sICAM-1 and sVCAM-1 in Palestinian BD patients.

Purpose of the Study:

  • To determine sICAM-1 and sVCAM-1 levels in Behçet's disease patients.
  • To correlate these levels with ocular and systemic disease activity.
  • To assess the impact of immunosuppressive treatment on these markers.

Main Methods:

  • Studied 51 Behçet's disease patients and 53 healthy controls.
  • Assessed disease activity via clinical history and ocular examination.
  • Measured peripheral venous sICAM-1 and sVCAM-1 using ELISA.

Related Experiment Videos

Main Results:

  • Both sICAM-1 and sVCAM-1 were significantly lower in patients receiving systemic immunosuppression.
  • Off treatment, sICAM-1 was higher in patients with active systemic disease but inactive eyes.
  • sVCAM-1 levels were not elevated in any patient group compared to controls.

Conclusions:

  • Systemic immunosuppression reduces sICAM-1 and sVCAM-1 levels in BD patients.
  • Elevated sICAM-1 suggests endothelial activation in active Behçet's disease.
  • sICAM-1 levels correlate with inflammatory activity in BD, including ocular involvement.